Repopulation of cancer cells during therapy: an important cause of treatment failure.
about
Cancer as an evolutionary and ecological processBig Data Analytics for Prostate RadiotherapyVEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsidePediatric and Adolescent Extracranial Germ Cell Tumors: The Road to CollaborationThe impact of the myeloid response to radiation therapyNanoparticle-based targeted therapeutics in head-and-neck cancerCancer stem cells and radioresistanceMetronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung CancerBiologic imaging of head and neck cancer: the present and the futureIdentifying new small molecule anti-invasive compounds for glioma treatmentThe Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the LungThe Indian scenario of head and neck oncology - Challenging the dogmasCyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during TherapyThe paradox role of caspase cascade in ionizing radiation therapyApoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunityDrug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic propertiesAnti-VEGF-A affects the angiogenic properties of tumor-derived microparticlesEnhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRIOxidative stress, inflammation, and cancer: how are they linked?Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy.Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.Reversibility of apoptosis in cancer cells.NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance.Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.Persistence to anti-cancer treatments in the stationary to proliferating transition.Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).S-1 for treatment of advanced hepatocellular carcinoma: a systematic review of the literature.In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer.Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.Mechanistic modelling of dynamic MRI data predicts that tumour heterogeneity decreases therapeutic response.Repopulation of tumor cells during fractionated radiotherapy and detection methods (Review).A multipurpose microfluidic device designed to mimic microenvironment gradients and develop targeted cancer therapeutics.Scaling dynamic response and destructive metabolism in an immunosurveillant anti-tumor system modulated by different external periodic interventions.Growth of breast cancer recurrences assessed by consecutive MRIHigh dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma modelMechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response.Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy.Radiosurgery for high-grade glioma.
P2860
Q22122026-148FF2E9-8EBD-4EE5-9D7D-35661253B791Q26744485-B305F129-165B-43A3-B0E3-5DE8B17770D3Q26770678-AB684ACA-EF00-473A-8624-B1A6470DD18DQ26797518-EAC7C0D0-8F44-4CD5-B565-8EE307505DD9Q26851643-F4C2DDB4-45E9-4EED-95DB-7B4CF7901EC7Q26999699-20D61C28-D474-4AB6-AF39-78782FDBD131Q27008368-D385169C-00B9-4ABF-9575-317F5EC35FAAQ27015786-547E4431-D892-4377-A984-D7C43F00364CQ27023296-BDC372EF-A870-49B9-8969-9B55F07BE1F2Q27025151-3660BC04-434B-408A-B358-68DC659E3938Q28070412-703116C2-9D30-4EDE-97A9-DB5E5CB253ABQ28072546-DABA1022-16B0-4F17-BC3A-B9512AF82D07Q28073252-F2BEC597-EC30-4FA8-985C-6EC36118A3DBQ28079723-B4E7BD7C-0EBB-406E-895C-9B77961F26EBQ28385358-A856D21D-5DE7-4154-BA08-47B53E3FF264Q28473512-724A52E9-369B-4D1B-B5A9-3188A6868DDDQ28538098-2CB09A30-DD8A-48EB-AD5E-0744C5EAB261Q28729080-A01FFFF3-8397-443E-9C13-29254E1BD68BQ29616835-D587EA04-68C6-4712-B062-D803FCBE1F5FQ30358961-3ABD5747-1685-4180-93A6-5BE309982F74Q30415832-BD6552DE-A9E2-4820-87F3-4511C32B861EQ30442799-3D93D206-D6F7-4364-8963-75273167E0CFQ30485754-A82FB87B-3D62-43B5-B8AD-C35C1B454DB6Q30486628-6FA2BCF3-C1B9-4439-BDB0-DD174D7D38D7Q30607164-FC9DC600-8E84-4898-968E-2A42E1FBCFA9Q30834504-74ADD812-84CB-4CF7-A5E6-B770D0B16B3CQ33372250-B5BEBBC3-5A33-4B26-B748-3F7EBB85A2B8Q33441277-F18DEFCD-79FF-49A9-AFD6-19FFC24A7025Q33553873-0CEDC462-7FB9-4CB1-89BE-9A79E13550E1Q33577450-F403121E-0B51-4CEA-BE39-3A6DC5A7F125Q33632105-D0ED89EB-CFCF-4AC4-8BDA-1CFC2A731812Q33727528-448F159A-9CF6-4908-A6B5-623F8B73AD1EQ33792264-BC3A56DB-7A13-43BC-9BD1-980398E34023Q33802674-DEFAAAF3-B643-48E1-8E05-7873F595C6ABQ33884067-55642E9F-8EEA-412F-8AE2-3715184CA312Q34091419-4A636945-84C6-4E7E-975E-ECEE803B0464Q34173568-00DD824A-CCC7-46D9-B5DC-9E5FF8389449Q34181806-CAAF6316-D453-426E-9462-DAA7471057EAQ34285363-D9B1C402-469C-4405-AF3F-0AA39E326C55Q34289982-96F851E5-5437-408A-A4CC-780C52A498AF
P2860
Repopulation of cancer cells during therapy: an important cause of treatment failure.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Repopulation of cancer cells during therapy: an important cause of treatment failure.
@ast
Repopulation of cancer cells during therapy: an important cause of treatment failure.
@en
type
label
Repopulation of cancer cells during therapy: an important cause of treatment failure.
@ast
Repopulation of cancer cells during therapy: an important cause of treatment failure.
@en
prefLabel
Repopulation of cancer cells during therapy: an important cause of treatment failure.
@ast
Repopulation of cancer cells during therapy: an important cause of treatment failure.
@en
P356
P1476
Repopulation of cancer cells during therapy: an important cause of treatment failure.
@en
P2093
Ian F Tannock
John J Kim
P2888
P304
P356
10.1038/NRC1650
P407
P577
2005-07-01T00:00:00Z